These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21968693)

  • 1. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus.
    Wang C; Chen LL; Pan HF; Leng RX; Qin WZ; Ye DQ
    Clin Rheumatol; 2012 Feb; 31(2):335-9. PubMed ID: 21968693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
    Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.
    Zhi-Chun L; Qiao-Ling Z; Zhi-Qin L; Xiao-Zhao L; Xiao-xia Z; Rong T
    Inflammation; 2012 Jun; 35(3):935-43. PubMed ID: 22009442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus.
    Liao L; Li S; Upreti B; Wang X; Yang Y; Lou X; Li L; Cui R; Liu S; Cheng Y; Xu J
    Lupus; 2023 Feb; 32(2):171-179. PubMed ID: 36418949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-induced expression of tumor necrosis factor-like weak inducer of apoptosis through ERα accelerates the progression of lupus nephritis.
    Xue L; Liu Z; Hu J; Huang J; Wen J; Liu Z
    Rheumatology (Oxford); 2016 Oct; 55(10):1880-8. PubMed ID: 27354685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
    Schwartz N; Rubinstein T; Burkly LC; Collins CE; Blanco I; Su L; Hojaili B; Mackay M; Aranow C; Stohl W; Rovin BH; Michaelson JS; Putterman C
    Arthritis Res Ther; 2009; 11(5):R143. PubMed ID: 19785730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.
    Liu ZC; Zhou QL
    Inflamm Res; 2012 Apr; 61(4):277-84. PubMed ID: 22297307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis.
    El-Shehaby A; Darweesh H; El-Khatib M; Momtaz M; Marzouk S; El-Shaarawy N; Emad Y
    J Clin Immunol; 2011 Oct; 31(5):848-56. PubMed ID: 21691937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
    Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
    J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
    Choe JY; Kim SK
    Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK as a target for therapy in systemic lupus erythematosus.
    Leng RX; Pan HF; Qin WZ; Wang C; Chen LL; Tao JH; Ye DQ
    Mol Biol Rep; 2011 Jan; 38(1):587-92. PubMed ID: 20358293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased UBASH3A mRNA Expression Levels in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.
    Liu J; Ni J; Li LJ; Leng RX; Pan HF; Ye DQ
    Inflammation; 2015 Oct; 38(5):1903-10. PubMed ID: 25876712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is serum TWEAK a useful biomarker of neuropsychiatric systemic lupus erythematosus?
    Balajkova V; Olejarova M; Moravcova R; Kozelek P; Posmurova M; Hulejova H; Senolt L
    Physiol Res; 2020 Apr; 69(2):339-346. PubMed ID: 32199014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of TWEAK-Fn14 axis in lupus, a disease related to autoimmunity and fibrosis.
    Xu Y; Wei HT; Jing HY; Tan XY; Zhou XT; Ma YR
    Int J Rheum Dis; 2022 Jan; 25(1):21-26. PubMed ID: 34716660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
    Salem MN; Taha HA; Abd El-Fattah El-Feqi M; Eesa NN; Mohamed RA
    Z Rheumatol; 2018 Feb; 77(1):71-77. PubMed ID: 27619369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
    Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
    J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Ma HY; Chen S; Cao WD; Min CT
    Ren Fail; 2021 Dec; 43(1):20-31. PubMed ID: 33307926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients.
    El-Karaksy SM; Kholoussi NM; Shahin RM; El-Ghar MM; Gheith Rel-S
    Gene; 2013 Sep; 527(1):211-4. PubMed ID: 23792015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.